Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132848) titled 'Human Efficacy Trial of Combined Hengfu Soft Capsule and Yirui Capsule' on Sept. 18.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: School of Public Health, Harbin Medical University
Condition:
Borderline elevation of blood lipids
Intervention:
(Placebo group): Hengfu Soft Capsule-placebo + Yirui Capsule-placebo:Take the Hengfu Soft Capsule placebo and the Yirui Capsule placebo at the same time each day. Both placebos should be taken twice daily, 2 capsules each time, preferably within 30 minutes after breakfast and dinner.
Yirui Capsule + Hengfu Soft Capsule-placebo: Take Yirui ...